Over the past decade, a large body of evidence has accumulated supporting the integration
of palliative care into oncology practice for patients with advanced cancer. The question is …

Hemato-oncology and palliative care teams: is it time for an... : Current Opinion in Supportive
and Palliative Care Hemato-oncology and palliative care teams: is it time for an integrated …

Background Despite its established benefits, palliative care (PC) is rarely utilized for
hematopoietic stem cell transplant (HSCT) patients. We sought to examine transplant …

Background: Little is known about quality of life (QOL), depression, and end-of-life (EOL)
outcomes among hospitalized patients with advanced cancer. Objective: To assess whether …

Allogeneic hematopoietic cell transplantation (HCT) is associated with significant morbidity
and mortality, making advance care planning (ACP) and management especially important …

Palliative care prioritizes symptom management and quality of life throughout the course of
serious illness. Regardless of whether care is inpatient or outpatient, primary or …

Palliative care during and following allogeneic hematopoieti... : Current Opinion in Supportive
and Palliative Care Palliative care during and following allogeneic hematopoietic stem cell …

Purpose Intensity of end-of-life care receives much attention in oncology because of
concerns that high-intensity care is inconsistent with patient goals, leads to worse caregiver …

Objective To describe palliative care integration into oncology, including several models that
facilitate this integration, important considerations when initiating a program, special …

Abstract Purpose of Review To highlight the breadth and types of mental distress
experienced by hematopoietic stem cell transplant (HSCT) patients and highlight the need …